Back Pain and Related Factors in Patients with COVID-19

Uz, Cuma; Umay, Ebru; Gündoğdu, İ̇̇brahim; Uz, Fatma

doi:10.21203/rs.3.rs-121763/v1

Cited by 3 publications

(2 citation statements)

References 19 publications

(21 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Many other studies have investigated pain, pain management, pain perception, and COVID-19 vaccination [ 31 ]. However, the fact that this study was conducted specifically among COVID-19-positive patients with back pain in a COVID-19 ward constitutes the main novelty of this study.…”

Section: Discussionmentioning

confidence: 99%

Vaccine hesitancy in patients with COVID-19 who have back pain

Türken¹,

Çapar²

2023

PHRP

View full text Add to dashboard Cite

Objectives: Musculoskeletal pain is among the most common symptoms in patients diagnosed with coronavirus disease 2019 (COVID-19), and it has placed a significant burden on health worldwide during the pandemic. This study explored vaccine hesitancy and associated factors in patients with positive COVID-19 polymerase chain reaction test results who were hospitalized and had back pain.Methods: A cross-sectional study was conducted among 170 hospitalized COVID-19 patients over 18 years of age. Data were analyzed using descriptive statistics with IBM SPSS ver. 25.0.Results: COVID-19 patients who were married considered COVID-19 vaccinations riskier than unmarried COVID-19 patients. Patients who had not been vaccinated expressed higher levels of distrust towards COVID-19 vaccines than patients who had been vaccinated. Participants had relatively little hesitation toward the Sinovac vaccine. High vaccine confidence was found in all participants regardless of vaccination status. Those who had not received the COVID-19 vaccine reported higher risk perceptions than those who had received at least 1 dose of any COVID-19 vaccine.Conclusion: Measurements of the hesitancy of vaccinated and non-vaccinated patients or members of society towards vaccines can be an important parameter for health authorities to find solutions.

show abstract

Section: Discussionmentioning

confidence: 99%

Vaccine hesitancy in patients with COVID-19 who have back pain

Türken¹,

Çapar²

2023

PHRP

View full text Add to dashboard Cite

show abstract

“…However, in that study, 2377 patients were in critically ill condition. Uz et al[34] conducted a study on 99 COVID-19 polymerase chain reaction-positive inpatients. The mean age of the patients (53 male and 46 female) was 48.80 ± 14.64 years, and 59 (60%) patients had at least one comorbidity.…”

mentioning

confidence: 99%

Increased Frequency of Low Back Pain in Recent Times: Does the Answer Lie in COVID-19?

Sathu,

Kumar,

Maley

et al. 2023

Cureus

View full text Add to dashboard Cite

show abstract

A relationship between musculoskeletal pain and prognosis in hospitalized COVID-19 patients

Demirel

Şahin

Utlu

et al. 2021

Journal of Health Sciences and Medicine

View full text Add to dashboard Cite

Introduction:Musculoskeletal system complaints are often encountered in patients with COVID-19. The aim of this study was to evaluate the frequency of symptoms such as arthralgia, myalgia, and arthritis in hospitalized patients and their relationship with the final prognosis. Material and Method: Complaints related to myalgia, arthralgia, arthritis-like symptoms, laboratory parameters, VAS scores and localized painful areas of 154 hospitalized patients who were treated with a COVID-19 diagnosis were recorded on admission and during their hospitalization period. The relationship between these clinical and laboratory data and the duration of hospital stays, need for intensive care and death-recovery states was evaluated. Results: Of 154 cases, 45.5% (n=70) were female, 71.4% (n=110) had myalgia while 55.8% (n=86) had arthralgia. Mean VAS value was 6.39±2.04. The most commonly reported painful locations were dorsum in 68.2% (n=75) and chest in 63.6% (n=70) of the patients. The death rate was significantly higher in patients with dorsum pain. 25-0H-Vitamin D levels did not have a significant effect on the prognosis and in terms of needing intensive care. Conclusion:Myalgia and arthralgia are present in a significant part of patients with a diagnosis of COVID-19. Pain localized in the chest and dorsum area is associated with bad prognosis.

show abstract

Back Pain and Related Factors in Patients with COVID-19

Cited by 3 publications

References 19 publications

Vaccine hesitancy in patients with COVID-19 who have back pain

Vaccine hesitancy in patients with COVID-19 who have back pain

Increased Frequency of Low Back Pain in Recent Times: Does the Answer Lie in COVID-19?

A relationship between musculoskeletal pain and prognosis in hospitalized COVID-19 patients

Contact Info

Product

Resources

About